News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
296,133 Results
Type
Article (16862)
Company Profile (46)
Press Release (279225)
Multimedia
Podcasts (15)
Webinars (5)
Section
Business (81515)
Career Advice (690)
Deals (15040)
Drug Delivery (36)
Drug Development (43255)
Employer Resources (75)
FDA (7597)
Job Trends (6470)
News (149180)
Policy (14025)
Tag
Academia (1436)
Academic (1)
Accelerated approval (2)
Adcomms (7)
Allergies (44)
Alliances (21711)
ALS (57)
Alzheimer's disease (649)
Antibody-drug conjugate (ADC) (46)
Approvals (7646)
Artificial intelligence (162)
Autoimmune disease (15)
Automation (9)
Bankruptcy (124)
Best Places to Work (5557)
BIOSECURE Act (6)
Biosimilars (55)
Biotechnology (32)
Bladder cancer (57)
Brain cancer (16)
Breast cancer (182)
Cancer (1377)
Cardiovascular disease (109)
Career advice (585)
Career pathing (13)
CAR-T (75)
Cell therapy (223)
Cervical cancer (15)
Clinical research (36375)
Collaboration (489)
Compensation (228)
Complete response letters (4)
COVID-19 (2180)
CRISPR (25)
C-suite (119)
Cystic fibrosis (42)
Data (1468)
Denatured (7)
Depression (23)
Diabetes (150)
Diagnostics (3086)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (28)
Drug discovery (62)
Drug pricing (47)
Drug shortages (18)
Duchenne muscular dystrophy (50)
Earnings (31338)
Editorial (19)
Employer branding (6)
Employer resources (67)
Events (41663)
Executive appointments (454)
FDA (8425)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (442)
Gene editing (46)
Generative AI (10)
Gene therapy (170)
GLP-1 (353)
Government (2057)
Grass and pollen (3)
Guidances (86)
Healthcare (8549)
Huntington's disease (12)
IgA nephropathy (10)
Immunology and inflammation (45)
Indications (14)
Infectious disease (2283)
Inflammatory bowel disease (76)
Inflation Reduction Act (4)
Influenza (45)
Intellectual property (45)
Interviews (113)
IPO (6243)
IRA (21)
Job creations (1235)
Job search strategy (519)
Kidney cancer (7)
Labor market (9)
Layoffs (116)
Leadership (9)
Legal (2912)
Liver cancer (37)
Lung cancer (198)
Lymphoma (90)
Machine learning (3)
Management (23)
Manufacturing (149)
MASH (46)
Medical device (5348)
Medtech (5350)
Mergers & acquisitions (9180)
Metabolic disorders (347)
Multiple sclerosis (59)
NASH (16)
Neurodegenerative disease (39)
Neuropsychiatric disorders (7)
Neuroscience (952)
NextGen: Class of 2025 (2601)
Non-profit (2137)
Now hiring (5)
Obesity (157)
Opinion (128)
Ovarian cancer (43)
Pain (61)
Pancreatic cancer (48)
Parkinson's disease (82)
Partnered (10)
Patents (94)
Patient recruitment (69)
Peanut (22)
People (25452)
Pharmaceutical (14)
Pharmacy benefit managers (9)
Phase I (9559)
Phase II (15688)
Phase III (13747)
Pipeline (762)
Policy (66)
Postmarket research (1573)
Preclinical (3640)
Press Release (59)
Prostate cancer (64)
Psychedelics (13)
Radiopharmaceuticals (110)
Rare diseases (181)
Real estate (2315)
Recruiting (26)
Regulatory (10237)
Reports (17)
Research institute (1330)
Resumes & cover letters (91)
Rett syndrome (4)
RNA editing (1)
RSV (28)
Schizophrenia (37)
Series A (84)
Series B (56)
Service/supplier (4)
Sickle cell disease (27)
Special edition (4)
Spinal muscular atrophy (86)
Sponsored (8)
Startups (1498)
State (1)
Stomach cancer (5)
Supply chain (39)
Tariffs (10)
The Weekly (8)
Vaccines (473)
Venture capitalists (9)
Weight loss (81)
Women's health (19)
Worklife (7)
Date
Today (125)
Last 7 days (523)
Last 30 days (1764)
Last 365 days (17524)
2025 (6845)
2024 (16490)
2023 (17152)
2022 (23079)
2021 (25573)
2020 (25106)
2019 (20214)
2018 (15335)
2017 (14248)
2016 (13730)
2015 (16415)
2014 (11718)
2013 (9525)
2012 (10501)
2011 (11065)
2010 (10286)
Location
Africa (354)
Alabama (17)
Alaska (4)
Arizona (62)
Arkansas (5)
Asia (17769)
Australia (2974)
California (3122)
Canada (990)
China (279)
Colorado (163)
Connecticut (183)
Delaware (113)
Europe (44994)
Florida (391)
Georgia (123)
Idaho (17)
Illinois (287)
India (17)
Indiana (139)
Iowa (7)
Japan (136)
Kansas (43)
Kentucky (12)
Louisiana (8)
Maine (15)
Maryland (407)
Massachusetts (2308)
Michigan (67)
Minnesota (167)
Missouri (38)
Montana (7)
Nebraska (9)
Nevada (40)
New Hampshire (69)
New Jersey (1723)
New Mexico (23)
New York (1115)
North Carolina (998)
North Dakota (9)
Northern California (1338)
Ohio (86)
Oklahoma (6)
Oregon (15)
Pennsylvania (628)
Puerto Rico (4)
Rhode Island (14)
South America (570)
South Carolina (10)
South Dakota (1)
Southern California (1138)
Tennessee (52)
Texas (464)
United States (13038)
Utah (50)
Virginia (77)
Washington D.C. (23)
Washington State (310)
West Virginia (2)
Wisconsin (52)
296,133 Results for "pharming group n v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharming Group to participate in June 2024 investor conferences
Leiden, the Netherlands, June 3, 2024: Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of June:.
June 3, 2024
·
1 min read
Press Releases
Pharming Group to report first quarter 2025 financial results on May 8
April 24, 2025
·
1 min read
Press Releases
Pharming Group to participate in April 2024 investor conferences
March 28, 2025
·
1 min read
Pharming Group to participate in May 2024 investor conference
Leiden, the Netherlands, May 20, 2024: Pharming Group N.V. announces that Pharming’s management will participate in the following investor conference in the month of May.
May 20, 2024
·
1 min read
Press Releases
Pharming Group reports first quarter 2025 financial results and provides business update
May 8, 2025
·
25 min read
Press Releases
Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director
May 1, 2025
·
3 min read
Press Releases
Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
April 28, 2025
·
5 min read
Pharming Group to participate in April 2024 investor conferences
Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of April:.
April 3, 2024
·
1 min read
Press Releases
Pharming Group to participate in March 2025 investor conference
February 28, 2025
·
1 min read
Business
Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders
Leiden, the Netherlands, May 21, 2024: Pharming Group N.V. announces that at its Annual General Meeting of Shareholders held , all proposals were approved.
May 21, 2024
·
1 min read
1 of 29,614
Next
